Cargando…
Mutation position is an important determinant for predicting cancer neoantigens
Tumor-specific mutations can generate neoantigens that drive CD8 T cell responses against cancer. Next-generation sequencing and computational methods have been successfully applied to identify mutations and predict neoantigens. However, only a small fraction of predicted neoantigens are immunogenic...
Autores principales: | Capietto, Aude-Hélène, Jhunjhunwala, Suchit, Pollock, Samuel B., Lupardus, Patrick, Wong, Jim, Hänsch, Lena, Cevallos, James, Chestnut, Yajun, Fernandez, Ajay, Lounsbury, Nicolas, Nozawa, Tamaki, Singh, Manmeet, Fan, Zhiyuan, de la Cruz, Cecile C., Phung, Qui T., Taraborrelli, Lucia, Haley, Benjamin, Lill, Jennie R., Mellman, Ira, Bourgon, Richard, Delamarre, Lélia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144530/ https://www.ncbi.nlm.nih.gov/pubmed/31940002 http://dx.doi.org/10.1084/jem.20190179 |
Ejemplares similares
-
Cancer neoantigens and immunogenicity: mutation position matters
por: Capietto, Aude-Hélène, et al.
Publicado: (2020) -
Sources of Cancer Neoantigens beyond Single-Nucleotide Variants
por: Capietto, Aude-Hélène, et al.
Publicado: (2022) -
An Integrated Genomic, Proteomic, and Immunopeptidomic Approach to Discover Treatment-Induced Neoantigens
por: Olsson, Niclas, et al.
Publicado: (2021) -
Peroxynitrite promotes immune evasion by reducing tumor antigenicity
por: Capietto, Aude-Hélène, et al.
Publicado: (2022) -
Presentation of Exogenous Antigens on Major Histocompatibility Complex (MHC) Class I and MHC Class II Molecules Is Differentially Regulated during Dendritic Cell Maturation
por: Delamarre, Lélia, et al.
Publicado: (2003)